Brilliant Blue has been researched along with kn 62 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Markwardt, F; Schmalzing, G; Seyffert, C | 1 |
| Escartin, C; Nagasawa, K; Swanson, RA | 1 |
2 other study(ies) available for Brilliant Blue and kn 62
| Article | Year |
|---|---|
Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Benzenesulfonates; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Kinetics; Magnesium; Oocytes; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X7; Suramin; Time Factors; Xenopus laevis | 2004 |
Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Apyrase; Astrocytes; Benzenesulfonates; Benzoxazoles; Cell Line; Cells, Cultured; Gene Knockdown Techniques; Humans; Ligands; Mice; Phenolsulfonphthalein; Propidium; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Small Interfering; Suramin | 2009 |